Literature DB >> 2074521

Bladder cancer survival statistics.

C R Smart1.   

Abstract

Bladder cancer is the most common urinary system malignancy and the fourth most frequently occurring cancer among men. Although it occurs in both sexes, the disease is 2.5 times more likely to develop in men, probably because of life-style factors such as smoking and occupational exposures. The estimated 47,000 new cases and 10,200 bladder cancer deaths in 1989 constitute almost 5% of all new cancer cases and approximately 2.2% of all cancer deaths. More than half of new cases occur in persons 70 and older. The incidence rate for whites is approximately 37% greater than the rate for blacks. (However, only 50% of blacks have localized disease at diagnosis as compared with 72% for whites.) The 51% increase in incidence over 35 years has been greatly tempered through earlier detection and improved treatment resulting in improved survival and a 33% reduction in mortality. Overall survival has improved by more than 45% during the past 35 years, within each stage as well as overall. The relative 5-year survival rates for whites v blacks are overall, 81% v 58%; for localized disease, 88% v 74%; for regional disease, 44% v 30%; for distant disease, 9% v 8%; and for unknown stage, 61% v 35%.

Entities:  

Mesh:

Year:  1990        PMID: 2074521     DOI: 10.1097/00043764-199009000-00035

Source DB:  PubMed          Journal:  J Occup Med        ISSN: 0096-1736


  1 in total

1.  Tobacco-Specific Carcinogens Induce Hypermethylation, DNA Adducts, and DNA Damage in Bladder Cancer.

Authors:  Feng Jin; Jose Thaiparambil; Sri Ramya Donepudi; Venkatrao Vantaku; Danthasinghe Waduge Badrajee Piyarathna; Suman Maity; Rashmi Krishnapuram; Vasanta Putluri; Franklin Gu; Preeti Purwaha; Salil Kumar Bhowmik; Chandrashekar R Ambati; Friedrich-Carl von Rundstedt; Florian Roghmann; Sebastian Berg; Joachim Noldus; Kimal Rajapakshe; Daniel Gödde; Stephan Roth; Stephan Störkel; Stephan Degener; George Michailidis; Benny Abraham Kaipparettu; Balasubramanyam Karanam; Martha K Terris; Shyam M Kavuri; Seth P Lerner; Farrah Kheradmand; Cristian Coarfa; Arun Sreekumar; Yair Lotan; Randa El-Zein; Nagireddy Putluri
Journal:  Cancer Prev Res (Phila)       Date:  2017-08-29
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.